As of 2025-10-30, the Relative Valuation of Myriad Genetics Inc (MYGN) is (55.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.13 USD, the upside of Myriad Genetics Inc based on Relative Valuation is -786.9%.
The range of the Relative Valuation is (47.82) - (68.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.7x - 16.2x | 12.0x |
| Forward P/E multiples | 11.3x - 16.9x | 14.2x |
| Fair Price | (47.82) - (68.96) | (55.84) |
| Upside | -688.1% - -948.3% | -786.9% |
| Date | P/E |
| 2025-10-27 | -1.91 |
| 2025-10-24 | -1.92 |
| 2025-10-23 | -1.90 |
| 2025-10-22 | -1.85 |
| 2025-10-21 | -1.90 |
| 2025-10-20 | -1.86 |
| 2025-10-17 | -1.84 |
| 2025-10-16 | -1.90 |
| 2025-10-15 | -1.91 |
| 2025-10-14 | -1.84 |
| 2025-10-13 | -1.85 |
| 2025-10-10 | -1.77 |
| 2025-10-09 | -1.82 |
| 2025-10-08 | -1.80 |
| 2025-10-07 | -1.77 |
| 2025-10-06 | -1.88 |
| 2025-10-03 | -1.90 |
| 2025-10-02 | -1.78 |
| 2025-10-01 | -1.82 |
| 2025-09-30 | -1.70 |
| 2025-09-29 | -1.70 |
| 2025-09-26 | -1.81 |
| 2025-09-25 | -1.83 |
| 2025-09-24 | -1.82 |
| 2025-09-23 | -1.81 |
| 2025-09-22 | -1.85 |
| 2025-09-19 | -1.83 |
| 2025-09-18 | -1.81 |
| 2025-09-17 | -1.74 |
| 2025-09-16 | -1.77 |
| 2025-09-15 | -1.72 |
| 2025-09-12 | -1.70 |
| 2025-09-11 | -1.81 |
| 2025-09-10 | -1.62 |
| 2025-09-09 | -1.64 |
| 2025-09-08 | -1.63 |
| 2025-09-05 | -1.56 |
| 2025-09-04 | -1.60 |
| 2025-09-03 | -1.60 |
| 2025-09-02 | -1.62 |
| 2025-08-29 | -1.50 |
| 2025-08-28 | -1.46 |
| 2025-08-27 | -1.40 |
| 2025-08-26 | -1.37 |
| 2025-08-25 | -1.39 |
| 2025-08-22 | -1.42 |
| 2025-08-21 | -1.37 |
| 2025-08-20 | -1.30 |
| 2025-08-19 | -1.30 |
| 2025-08-18 | -1.34 |